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Mitochondria are involved in a plethora of vital processes in the cell.
Apart from the generation of adenosine triphosphate (ATP), they serve
as a metabolic hub that interconnects various anabolic and catabolic
processes, including oxidative phosphorylation, the tricarboxylic acid
(TCA) cycle, the β-oxidation of fatty acids, and the steroidogenesis or
heme synthesis. The important metabolic role of mitochondria is
reﬂected by their involvement in multiple signaling pathways in the
cell, including calcium signaling and apoptosis. To fulﬁll these multiple
functions, mitochondria encompass a large proteome of roughly 1000
proteins [1,2]. Althoughmitochondria contain an autonomous genome,
the great majority of mitochondrial proteins are encoded in nuclear
DNA and translated in the cytoplasm. These precursor proteins are
imported into mitochondria by specialized machineries that decode
structural signals in the amino acid sequence of precursors to properly
distribute them into four mitochondrial compartments: outer mem-
brane (OM), intermembrane space (IMS), inner membrane (IM), and
matrix.
Multiple functions of mitochondria require feedback mechanisms to
reﬂect the functional status of mitochondria. For example, mitochondria
can send retrograde signals to the cytoplasm by modulating calcium sig-
naling, which depends on the mitochondrial electrochemical potential
(ΔΨ) across the IM. Reactive oxygen species (ROS) can also play a role
in retrograde signaling as a functional output of respiratory chain activity.
In this review, we focus on retrograde signaling that directly involves
mechanisms of protein transport into mitochondria. The necessity toMolecular and Cell Biology in
wski).
. This is an open access article underimport amajority ofmitochondrial proteome from the cytoplasmexposes
the organelle to a constant ﬂux of precursors across their membranes,
which can be interrupted as a result ofmitochondrial dysfunction. Protein
import into mitochondria acts as a signaling pathway to reﬂect the func-
tional status of these organelles. We also discuss novel concepts of retro-
grade trafﬁcking of mitochondrial proteins and signaling through factors
that are encoded in the mitochondrial genome.
2. Major protein import pathways to mitochondria
2.1. Translocase of the outer membrane as a common entry gate
The synthesis of mitochondrial proteins in the cytosol requires a
mechanism that can organize the transfer of precursor proteins across
the OM. All canonical import pathways require the presence of Tom40
protein, which constitutes a channel of the translocase of the outer
membrane (TOM) complex [3–6] (Fig. 1). Apart from the channel itself,
the TOM complex contains a number of receptor proteins, such as
Tom20, Tom22, and Tom70, that participate in recognition of the incom-
ing precursor proteins. Import through the TOM complex depends on
interactions between precursor proteins with receptor domains that
are exposed by subunits of the TOM complex. The receptors bind the
precursor with increasing afﬁnity as it gradually translocates across
the OM [4,5,7]. In addition to the channel and receptors, the TOM com-
plex contains accessory subunits Tom5, Tom6, and Tom7 that are re-
sponsible for assembly and stability of the complex [4,5,8]. The TOM
complex contains three Tom40 subunits, but it can dynamically ex-
changewith a dimeric form,which is presumably an assembly interme-
diate [9]. Active TOM complexes are located in discrete subdomains of
the OM that are close to openings of cristae in the IM, known as cristae
junctions [10].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Protein transport pathways into mitochondria. Mitochondrial proteins are synthesized on the cytosolic ribosomes and delivered as precursor forms to the translocase of the outer
membrane (TOM), to be directed to their ﬁnal mitochondrial destinations with assistance from speciﬁc sorting machineries. a) Precursors with α-helical transmembrane segments are
directed to the insertase of the mitochondrial outer membrane (MIM) for assembly. b) β-barrel precursors are transported to the sorting and assembly machinery (SAM) by the small
Tim chaperone proteins. c) Cysteine-rich precursor proteins are guided into the IMS via the mitochondrial intermembrane space assembly (MIA) pathway. d) Precursors with
cleavable N-terminal presequences are directed to the matrix and IM via TIM23. TIM23 is associated with the presequence translocase-associated motor (PAM) and transfers precursor
proteins into the matrix in an ATP-dependent manner. Upon delivery into the matrix, the presequences are recognized and cleaved by mitochondrial processing peptidase (MPP). e)
Hydrophobic precursors of carrier proteins with internal targeting signals are transported through the IMS by small TIM chaperone complexes that deliver precursors to the TIM22
complex. The membrane insertion via the TIM23 and TIM22 requires the electrochemical potential (ΔΨ) across the IM.
126 M. Wasilewski et al. / Biochimica et Biophysica Acta 1864 (2017) 125–137Certain classes of precursor proteins have long been known to differ-
entially interact with the TOM complex. Precursor proteins that are
targeted to mitochondria by the cleavable mitochondrial targeting sig-
nal, called a presequence, are ﬁrst recognized by Tom20 before they in-
teract with Tom22. Hydrophobic precursors of carrier proteins that
contain an integral targeting signal require the presence of the Tom70
receptor. On theirway through the channel of Tom40, both types of pro-
tein precursors interact with the pore, but the pattern of interacting res-
idues of Tom40 is different for the presequence and carrier precursors
[9,11].
Serving as the main entry gate for proteins, the TOM complex is a po-
tential target for cytosolic factors that regulate the import of precursor
proteins into mitochondria. In fact, the TOM complex contains around
30 phosphorylation sites, the majority of which localize to cytosolic do-
mains of receptor proteins [12]. In Saccharomyces cerevisiae, two cytosolic
kinases phosphorylate subunits of the TOM complex and apparently af-
fect the functions of the TOM complex in opposite ways. Casein kinase
2 (CK2) promotes the biogenesis of the TOMcomplexbyphosphorylating
the Tom22 precursor to control its import into the OM and promote the
assembly of Tom20 with the complex. Conversely, protein kinase A
(PKA) impairs the assembly of the TOM complex through phosphoryla-
tion of the Tom40 precursor to inhibit its import [13]. PKA also targets
the Tom70 receptor subunit and decreases the import of carrier precur-
sors under fermentative conditionswhen the demand for oxidative phos-
phorylation is reduced. In higher eukaryotes, the tethering of PKA to
mitochondria has been described, but its involvement in the regulation
of the TOM complex is unknown [14].
2.2. Biogenesis of outer membrane proteins
Integral proteins of the OM are incorporated into the membrane fol-
lowing several routes, depending on their topology. Many OM proteins,
known as signal-anchored proteins (e.g., Tom20 and Tom70), are an-
chored in the membrane by an N-terminal α-helix and expose the C-
terminal part to the cytosol. From a topological point of view, these pro-
teins do not require full translocation through the membrane. In yeast,precursors of signal-anchoredproteins are imported by themitochondri-
al import (MIM) complex, which consists of Mim1 and Mim2 proteins
[15–19] (Fig. 1). An exceptional signal-anchored protein, OM45, reveals
an inverted topology in which the bulk of the protein mass is exposed
to the IMS [20,21]. In this case, the precursor ﬁrst translocates through
the TOM complex into the IMS in a Tim23-dependent manner and
then assembles into the membrane with a help of the MIM complex.
The MIM complex also participates in the biogenesis of multispanning
proteins, such as Ugo1, but in this case the import of precursors also re-
quires the Tom70 receptor [22,23]. Another example of an OM
multispanning protein is Mcp3. Similar to OM45, Mcp3 ﬁrst translocates
to the IMSwith the help of Tim23 before it is integrated to the OMby the
MIM complex [24]. In contrast to fungi, no orthologues of eitherMim1 or
Mim2 have been identiﬁed in metazoans to date; therefore, the mecha-
nism of the biogenesis of signal-anchored and multispanning proteins
remains elusive.
Many OM proteins are integrated into the membrane by a trans-
membrane domain that is located at the C-terminus, referred to as
tail-anchored (TA) proteins [4,25]. Among them are proteins (e.g., Mff,
Fis1 and members of the Bcl-2 family) that are directly involved in the
control of the functional state of mitochondria or of the mitochondrial
pathway of apoptosis as well as proteins that are involved in mitochon-
drial dynamics [26–28]. Some TA proteins participate in coordination of
mitochondriamotilitywith Ca2+ signals or organize signaling platforms
[29,30]. Several aspects of the biogenesis of TA proteins remain un-
known. In particular, targetingmitochondrial TA proteins to the OM re-
quires a speciﬁc mechanism that can differentiate them from TA
proteins that are targeted to the endoplasmic reticulum (ER) [31]. An
appropriate lipid composition of the OM appears to promote their
targeting; at least in the case of some mitochondrial TA proteins, this
is sufﬁcient for their incorporation into the membrane [32,33]. The
proper localization of mitochondrial TA proteins is safeguarded by pro-
teolysis both before and after their insertion into the membrane
[34–36].
The OM is exceptional among other eukaryotic membranes because
it contains a conserved class of proteins that is characterized by a β-
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5,37]. In yeast, the biogenesis of β-barrel proteins requires the sorting
and assembly (SAM) complex (Fig. 1). It is composed of the β-barrel
protein Sam50, which integrates precursors into the membrane, and
subunits Sam35 and Sam37, which participate in substrate recognition
and complex stability. The precursors of β-barrel proteins cross the
OM using Tom40 channel. They are received in the IMS by small Tim
chaperones that prevent their aggregation and ascertain their safe pas-
sage to the SAM complex that incorporates the precursors into the
membrane [38,39]. The biogenesis of β-barrel proteins also depends
on Mic60 protein, a core subunit of the mitochondrial contact site and
cristae organizing system (MICOS) complex, which physically interacts
with the SAM complex [40]. The SAM complex also contains an accesso-
ry subunit, Mdm10, which might play a regulatory role. Apart from the
interactionwith the SAMcomplex,Mdm10 is involved inmitochondria-
ER contact sites that are deﬁned in yeast by the ER-mitochondria en-
counter structure (ERMES) complex [41].
2.3. Mitochondrial intermembrane space import and assembly pathway
Small soluble proteins of the IMS are imported by themitochondrial
IMS import and assembly (MIA) pathway, which consists of two com-
ponents in yeast: Mia40 and Erv1 [42–47] (Fig. 1). In higher eukaryotes,
orthologues ofMIA components are known asMIA40/CHCHD4 and ALR,
respectively [47–53]. Canonical substrates of theMIA pathway are small
Tim chaperones (e.g., Tim9) and assembly factors of the respiratory
complexes (e.g., Cox17). They are characterized by conserved twin
Cx3C or Cx9C motifs. Substrates of the MIA pathway can translocate
through theOMvia channels formed by Tom40,which is not in complex
with other canonical subunits of TOM like Tom22 [54]. Interestingly a
similar route of entry to mitochondria has been proposed for another
protein destined to the IMS, apocytochrome c [55]. After translocation
through the Tom40 channel Mia40 interacts with precursor proteins
both by covalent disulﬁde bond with one of the cysteine residues of
Cx3C or Cx9C motifs and by non-covalent interactions [46,56–58]. Sub-
sequently, Mia40 introduces intermolecular disulﬁde bridges to trigger
the precursor folding [59,60]. Oxidative folding executed by the MIA
pathway prevents the leakage of mature proteins from the IMS. The
MIA pathway is linked to the respiratory chain by cytochrome c,
which via Erv1 that reoxidizes Mia40, receives electrons that are de-
rived from the oxidized substrate protein. Consequently, the efﬁciency
of theMIA pathway correlates with the functional state of the respirato-
ry chain [61–63]. Redox state of the MIA pathway is also regulated by
IMS glutathione pool, which is connected with the cytosol pool via
porins in the OM [64]. In addition to canonical IMS substrates, MIA par-
ticipates in the biogenesis of other proteins, such as the IM translocases
Tim17 and Tim22, DNA repair enzyme APE1, mitochondrial ribosome
subunit Mrp10 and IMS protease Atp23 [65–70]. In addition to its in-
volvement in the import of protein precursors MIA inﬂuences function-
ing of mitochondrial calcium uniporter (MCU) by the control of MICU1-
MICU2 heterodimer formation [71].
2.4. TIM23 pathway
The majority of mitochondrial precursors use the presequence
translocase of the inner membrane (TIM23) pathway for import and
sorting in mitochondria [5,6,72,73] (Fig. 1). These precursors share a
structural feature, known as the presequence, which consists of an am-
phipathic helix at the N-terminus that is formed by a stretch of 30-80
amino acids. Presequence-containing precursor proteins can be sorted
to either the matrix or the IM, depending on secondary signals down-
stream from the presequence. After at least partial translocation across
the OM, precursor proteins are recognized by the TIM23 translocase in
the IMS, and the positively charged presequence initiates electrophoret-
ic translocation through the IM that is promoted by ΔΨ. In the matrix,
the presequence is excised by mitochondrial processing peptidase(MPP). Thus, mature proteins are shorter than their corresponding
precursors.
TIM23 is a multi-subunit complex that is localized in the IM. It has a
highly dynamic structure that adapts to different types of precursors
and reacts with conformational modiﬁcations to a changing environ-
ment. Precursors that contain solely the presequence are translocated
to the matrix through a mechanism that consumes energy. It requires
engagement of the presequence translocase-associated motor (PAM)
complex, which binds to the TIM23 complex and catalyzes the translo-
cation of the entire protein through TIM23 [6,74,75]. The key subunit of
the PAM complex, chaperone Hsp70, bindswith the precursor in cycles,
consequently promoting directional translocation through the TIM23
complex at the expense of ATP hydrolysis. The activity of the PAM com-
plex and its associationwith the TIM23 complex are regulated by acces-
sory subunits that, similar to Hsp70, can undergo cyclic binding to the
complex [5,6,72,76]. Tim44 is a subunit of the PAM complex that is pe-
ripherally associated with the TIM23 complex. Tim44 binds the incom-
ing protein precursor to coordinate its translocation and cyclic activity
of the PAM complex [77–79].
The second type of precursors contains a hydrophobic region down-
stream from the presequence, which can form a transmembrane do-
main. This domain, known as a “stop-transfer” signal, promotes the
lateral release of the protein from the TIM23 complex to the IM. For
this mode of TIM23 activity, the PAM complex is not required. Instead,
lateral sorting by the TIM23 complex requires the presence of Tim21
and Mgr2 [72,77,80–82].
Continuity of the IM is crucial for themaintenance ofΔΨ, a key attri-
bute of mitochondria. The TIM23 complex forms a large channel that is
capable of translocating long protein chains. An interesting line of inves-
tigation is determining themechanisms that control the permeability of
TIM23 and the inﬂuence that ΔΨ has on the complex. The TIM23 chan-
nel is kept sealed by interactions with Tim50 and becomes more prone
to opening in the presence of the presequence [83]. In the presence of
ΔΨ, the opening of the channel is regulated by interactions between
Tim23, Tim50, and the presequence. In addition opening of Tim23 chan-
nel depends on secondary structure of Tim17 that contains a disulﬁde
bond [69,70]. Fluctuations of ΔΨ promote large modiﬁcations of the
structure of the TIM23 complex. Disruptions ofΔΨ trigger structural re-
arrangements in the transmembrane domains of Tim23 and modify in-
teractions between Tim17 and Tim23 (i.e., core subunits of TIM23 that
form the channel) [84]. In summary, the TIM23 translocase is a dynamic
complex that is characterized by the architectural rearrangements in a
ΔΨ-dependent manner in response to precursor proteins.
2.5. TIM22 pathway
TIM22 translocase mediates the import and insertion of multi-pass
transmembrane proteins into the IM [3,85–88] (Fig. 1). The most promi-
nent substrates of TIM22 are mitochondrial metabolite carriers, such as
adenosine diphosphate ADP/ATP carriers, the phosphate carrier, and the
dicarboxylate carrier [89,90]. In addition to mitochondrial carriers, pro-
teins that are constituents of the IM translocases are also transported
via the TIM22 pathway, including Tim22 and two homologue proteins,
Tim17 and Tim23 [3,88]. In contrast to mitochondrial precursor proteins
with the cleavable presequence, carrier proteins contain several internal
import signals. Hydrophobic carrier precursors are prevented fromaggre-
gation or premature folding by cytosolic Hsp70 and Hsp90 chaperones
[91]. Once the precursors reach the TOM complex, they are recognized
by Tom70 and passed to the Tom40 channel in a process that requires
ATP. Transport from the TOM complex to the IM is facilitated by small
Tim chaperones that are located in the IMS. In yeast, the imported pro-
teins are associated with Tim9-Tim10 or Tim8-Tim13 and delivered to
TIM22 with the assistance of Tim9-Tim10-Tim12 [87]. In higher eukary-
otes, the biogenesis of precursors is facilitated by at least three different
complexes that are formed by TIMM8A, TIMM9, TIMM10A, TIMM10B
and TIMM13 [47,92–94]. Similar to precursors that are transported via
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IM. Tim22 forms two functionally voltage-activated pores and the inser-
tion process ends when a properly membrane-inserted carrier is assem-
bled into the functional dimer [95]. In yeast, the core component of the
TIM22 complex is formed by the central pore-forming subunit Tim22 to-
gether with Tim54, Tim18, and Sdh3. Interestingly, Tim22 possesses sta-
bilizing intramolecular disulﬁde bonds, an evolutionary conserved
feature [66,70,96]. Tim54 has a receptor role, with its C-terminal domain
exposed to the IMS where it interacts with Tim9-Tim10-Tim12 via pe-
ripherally attached Tim12. Tim18 stabilizes TIM22 but does not directly
participate in protein integration into the IM. Interestingly, Tim18 is ho-
mologous to Sdh4, which is a membrane integral subunit of complex II
(succinate dehydrogenase) [97,98]. Within complex II, Sdh4 strongly in-
teracts with Sdh3, which has also been identiﬁed as a subunit of the
TIM22 complex where it interacts with Tim18. This ﬁnding suggests the
co-evolution of mitochondrial protein import machineries and respirato-
ry chain complexes. In contrast to other translocase complexes, TIM22 is
poorly conserved between yeast and metazoans as it shares only one
common core subunit Tim22. A recently discovered mammalian subunit
TIM29 shares no homology with yeast proteins [99,100].
3. Proteolysis and degradation of mitochondrial proteins
Mitochondrial proteolytic systems fall into two general classes: ATP-
dependent and -independent proteases [101–103]. ATP-dependent
proteases belong to the AAA+ superfamily and share a conserved olig-
omeric structurewith a ring-likeATPase domain and barrel-shaped pro-
teolytic chamber. Members of this class are present in the matrix
(e.g., CLPP and LONP1/Pim1) and IM (e.g., m-AAA and i-AAA, exposed
to thematrix and IMS, respectively). ATP-independent proteases belong
to various classes and are present in the matrix (e.g., MPP), IM
(e.g., HTRA2, IMS processing peptidase (IMP), OMA1/Oma1, and PARL/
Pcp1), and IMS (e.g., Atp23). Mitochondrial proteases are involved in
thematuration of proteins and quality control of misfolded or damaged
proteins.
3.1. Maturation of mitochondrial proteins
To acquire full functionality, many mitochondrial proteins require
additional steps of maturation that can involve proteolytic processing,
the introduction of prosthetic groups, and assembly into protein com-
plexes [102,104]. The majority of mitochondrial proteins contain a
cleavable presequence that needs to be removed from the mature pro-
tein by MPP upon arrival to thematrix. In some proteins, proteolysis by
MPP exposes destabilizing amino acids at the N-terminus according to
the “N-end rule”, which in yeast are consecutively excised by such pep-
tidases as Icp55 and Oct1 [105]. Similarly, proteins that are encoded by
mtDNA undergo limited proteolysis on the N-terminus by aminopepti-
dase Map1 to remove methionine. The presequence is degraded to
amino acids by the presequence peptidase Mop112.
The IMS has another class of proteins that require further proteolytic
processing. These proteins are imported via the TIM23 pathway and are
laterally sorted to the IM. To complete theirmaturation, they require ex-
cision of the transmembrane domain. Cleavage can be performedby dif-
ferent proteases, depending on the substrate protein. In yeast, the
processing of cytochrome b2 involves IMP, whereas other proteins
(e.g., Ccp1 and Mgm1) are processed by rhomboid protease Pcp1.
Some target proteins have a complex pattern of processing, such as
mammalian Mgm1 orthologue OPA1 [106–108]. OPA1, similar to
Mgm1, is engaged in the fusion of mitochondria, which is ﬁne-tuned
by the balance between long (membrane) and short (soluble) forms
of OPA1. The processing of OPA1 is orchestrated by YME1L of the
AAA+ family and the metalloprotease OMA1, which differentially tar-
get various splicing isoforms of OPA1. Interestingly, both proteases are
engaged in the complex processing of OPA1 and undergo reciprocalcontrol to adequately tune the expression of different forms of OPA1
to the energetic state of the cell [109].
Several known mitochondrial proteins require processing before
they can be assembledwith destined complexes. In yeast theMgr2 sub-
unit of TIM23 translocase is targeted to mitochondria by a non-
canonical C-terminal sequence and integrated to the IM by two trans-
membrane domains [110]. The proper assembly of TIM23 translocase
requires excision of the C-terminal domain by IMP. Another example
is yeast mitochondrial ribosome subunit bL32m (previously known as
MrpL32 [111]), which is targeted tomitochondria by the N-terminal se-
quence excised the m-AAA protease upon import to the matrix [112].
The proteolytic maturation of MrpL32 is required for its proper integra-
tion into the mitochondrial ribosome.
3.2. Quality control of mitochondrial proteins
Protein turnover inmitochondria requires quality control systems to
degrade damagedormisfolded proteins. In contrast to the cytosol,mito-
chondria lack an autonomous system of conjugation-based protein deg-
radation, such as the ubiquitin-proteasome system (UPS), although
recent studies have reported the presence of ubiquitinated species in
the mitochondrial matrix [113]. Misfolded proteins or proteins that
fail to assemble into the destined complexes are recognized by AAA+
proteases. For example, pairs of small Tim chaperones form hetero-
oligomeric complexes that shepherd hydrophobic precursor proteins
on their way through the IMS.When the folding of one of the Tim chap-
erones is impaired, Yme1 protease (i.e., a yeast orthologue of human i-
AAA protease) degrades both partner proteins [114]. A similar mecha-
nism regulates the turnover of Ups1 and Ups2 proteins that are respon-
sible for the biogenesis of mitochondrial phospholipids [115]. In the
matrix, LONP1/Pim1 and m-AAA proteases have been implicated in
the clearance of misfolded, unassembled, and oxidatively damaged pro-
teins [116–118].
The proteasome degrades some mitochondrial proteins although
mitochondria do not contain the UPS. Since the large majority of mito-
chondrial proteins are produced in the cytosol, they can be subject to
proteasomal degradation. A fraction of newly synthesized MIA
pathway-dependent precursors is degraded in the cytosol before they
reach the IMS [119]. Similarly, defects in import trigger the accumula-
tion of precursors of the presequence import pathway in the cytosol
[120]. Activity of the UPS toward mitochondrial proteins is not limited
to degradation prior to their import. The turnover of some integral pro-
teins of the OM involves the UPS in a process that is known as
mitochondria-associated degradation (MAD) [121,122]. The degrada-
tion of membrane proteins by the UPS requires their extraction from
the OM, which is effectuated by a member of AAA+ family - Cdc48 in
yeast and p97/VCP in higher eukaryotes [123–125]. Cdc48/p97/VCP
also participates in the pathway of degradation of ER proteins, namely
the extraction of proteins from the ER lumen for degradation (ERAD)
pathway. Speciﬁcity toward mitochondrial proteins is controlled by
interacting partners of ATPase, which recognize ubiquitinated mem-
brane proteins [126]. Interestingly, theUPS is also involved in the degra-
dation of IMS proteins, which retrotranslocate to the cytosol. In yeast,
metabolic adaptation to fermentative growth conditions involves the
reduction and unfolding of small soluble proteins of the IMS. These pro-
teins are released to the cytosol through TOM and are degraded by the
proteasome [127].
4. Mitochondrial protein biogenesis in retrograde signaling
Mitochondrialﬁtness requires efﬁcient coordination between nucle-
ar and mitochondrial genomes to avoid the accumulation of unassem-
bled precursor proteins and consequently proteotoxic stress. In the
course of evolution, several mechanisms developed that employ the
biogenesis and transport of mitochondrial proteins to propagate infor-
mation about mitochondrial ﬁtness and proteostasis to the cytoplasm
129M. Wasilewski et al. / Biochimica et Biophysica Acta 1864 (2017) 125–137and nucleus. In this chapter, we discuss examples of retrograde signal-
ing frommitochondria that is involved in the preservation of functional
mitochondria.
4.1. Signaling proteotoxic stress in mitochondria: UPRmt
Mitochondria are subject to the constant ﬂux of precursor proteins
that are encoded by nuclear DNA that need to reach mitochondria and
mature to properly sustain numerous mitochondrial functions. The accu-
mulation of misfolded or damaged proteins in mitochondria poses a
threat to mitochondrial proteostasis. The perturbation of protein biogen-
esis in mitochondria triggers a broad transcriptional program in the nu-
cleus, known as the mitochondrial unfolded protein response (UPRmt),
which was originally identiﬁed in mammalian cells and is conserved in
nematodes, ﬂies, and mammals [128–130] (Fig. 2). Among proteins that
are upregulated during the UPRmt aremultiple mitochondrial chaperone
proteins that are responsible for protein synthesis and degradation and
counteract the deleterious effects of mitochondrial proteotoxic stress
[131,132]. The machinery that is involved in the UPRmt has been studied
intensively in nematodes (Fig. 2). In these animals, the UPRmt requires
the activity of two mitochondrial proteins: the matrix protease CLPP-1
and the ABC transporter of IM HAF-1 [133,134]. In isolatedmitochondria,
the degradation ofmatrix proteins by CLPP-1 leads to the accumulation of
peptides that are released frommitochondria byHAF-1. Both the protease
and the transporter are required for activation of theUPRmt. Consequent-
ly, downstream events are triggered by peptides outside mitochondria,
but the release of peptides has only been examined in organello. More-
over, unclear are which peptides are critical for activating downstream
factors of the UPRmt and whether there is any selectivity in this process.
Nematodes have at least two systems that receive information frommito-
chondria and control transcription in the nucleus [102]. ATFS-1 is a tran-
scription factor that presents a bimodal distribution in the cell. It
possesses two targeting sequences: the presequence that targets it to mi-
tochondria at the N-terminus and a nuclear localization signal at the C-
terminus [131]. Under basal conditions, the import to mitochondria pre-
vails, and ATFS-1 is rapidly degraded in the mitochondrial matrix by the
Lon protease. During mitochondrial stress, however, it translocates to
the nucleus where it binds to promoters of the regulated genes [135].
The mechanism that controls the differential localization of ATFS-1 isFig. 2. Themitochondrial unfolded protein response (UPRmt). UPRmt in C. elegans: Unfolded pro
released by the HAF-1 transporter in the IM. The activities of protease and transporter are neede
intomitochondria and degraded. However, duringmitochondrial stress, when the import efﬁcie
promotes the transcription ofmitochondrial proteins. Additionalmechanism of UPRmt involves
stress. These proteins are involved in an epigenetic pathway of chromatin remodeling. UPRmt
CLPP peptidase and released via unknown pathway to the cytosol. Additional UPRmt me
translocation to the nucleus and activation of CHOP10, transcription factor that participates innot fully understood. One proposal is that it depends on a general de-
crease in mitochondrial import that is induced by peptides that are re-
leased by HAF-1 [131]. This view is supported by the fact that induction
of the UPRmt by inhibiting mitochondrial import does not require the
presence of HAF-1 [136]. In the nucleus, ATFS-1 controls the expression
of multiple genes by both direct binding to regulatory elements in the
promoters and indirect interactions. Interestingly, ATFS-1 controls broad
adaptation of the cell to mitochondrial stress, in which it binds not only
to promoters of genes that are directly involved in the control of
proteotoxic stress in mitochondria but also enzymes of metabolic path-
ways, such as glycolysis and TCA. Transcriptomic analysis suggests that
ATFS-1 promotes glycolysis and represses the expression of TCA enzymes
and oxidative phosphorylation machinery (OXPHOS) proteins [135].
A second branch of the UPRmt involves DVE-1, UBL-5, and LIN-65,
which reside in the cytosol under basal conditions but can accumulate
in the nucleus during mitochondrial stress [133,137,138]. Similar to
ATFS-1, the exact mechanism of signaling between mitochondria and
these factors is unknown, but genetic interactions place DVE-1 down-
stream from CLPP-1. UBL-5 is considered to participate in the same
pathway because it coexists in a common complex with DVE-1. LIN-65
is required for the nuclear localization of DVE-1, but the nuclear locali-
zation of LIN-65 itself occurs partially independently from CLPP-1 activ-
ity. Recent studies show that DVE-1 and LIN-65 participate in the
reorganization of chromatin in the nucleus [138,139]. The execution of
the transcriptional response in the UPRmt requires speciﬁc rearrange-
ments in methylation patterns of histones, which lead to general con-
densation of the chromatin with separated low-density loci. DVE-1 co-
localizes with low-density chromatin in a LIN-65-dependent manner.
The human orthologue of DVE-1, SATB2, has been implicated in the
structural organization of active chromatin [140,141]. The UPRmt has
been proposed to trigger the rewiring of chromatin, characterized by
the focal stabilization of active chromatin that is controlled by DVE-1.
The epigenetic pathway, therefore, may prepare a structural framework
for the transcriptional factor ATFS-1, which regulates the activity of
downstream genes. This interpretation is supported by the fact that
ATFS-1 depletion does not inhibit the translocation of LIN-65 to the
nucleus.
Similar to nematodes, mammalian cells also activate speciﬁc tran-
scriptional programs in response to mitochondrial stress, including theteins in themitochondrial matrix are processed by themitochondrial CLPP-1 protease and
d for the activation of UPRmt. UPRmt involves action of ATFS-1which is normally imported
ncy is reduced, ATFS-1 accumulates in the cytosol and translocases to the nucleuswhere it
cytosolic DVE-1, UBL-5 and LIN-65which translocate to the nucleus duringmitochondrial
in mammals: Unfolded proteins inside mitochondria are processed by the mitochondrial
chanisms may involve PRK and JNK kinases that phosphorylate c-Jun resulting in its
transcription of mitochondrial proteins.
Fig. 3. Consequences of defective protein import into mitochondria. Increased levels of
mistargeted precursor proteins in the cytosol trigger unfolded protein response
activated by mistargeting of proteins (UPRam) resulting in more efﬁcient proteasomal
assembly and increased protein degradation. Mitochondria defective in protein import
signal to cytosolic translation causing its pausing.
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(Fig. 2). Moreover, the involvement of mitochondrial proteases in com-
municating mitochondrial stress appears to be conserved, in which the
activity of matrix protease CLPP is required for the induction of the
UPRmt in some mammalian models [132]. Nevertheless, our under-
standing of the mammalian UPRmt is still elusive. For example, the in-
volvement of CLPP has been recently questioned in DARS2-defﬁcient
mice, in which the expression of typical UPRmt markers occurred inde-
pendently from the presence of the protease [143]. Moreover, unclear is
the way in which mitochondria propagate information about such
stress. Some light is being shed by the types of experimental manipula-
tions that have been proven to successfully induce theUPRmt, including
protein aggregation in the matrix, the abolition of mitochondrial trans-
lation, and the impairment of protein import [132,144,145]. These trig-
gers should induce the accumulation ofmisfolded proteins in thematrix
either directly or indirectly by introducing an imbalance between pro-
teins that are encoded by nuclear and mitochondrial genomes, which
could be degraded by CLPP to produce signaling peptides. Recently the
transcription factor ATF5 was postulated to fulﬁll a similar role to
ATFS-1 in mammals as it displays a dual localization to mitochondria
and the nucleus and it regulates expression of several UPRmt-induced
genes [146]. Alternatively, transmission of stress signals to the nucleus
could depend on PKR and JNK kinases [147,148]. PKR is a kinase that
participates in the antiviral innate response, but currently unknown is
the way in which it is activated by mitochondrial stress. Interestingly,
the antiviral innate response requires a signalosome that is orchestrated
by the OM protein MAVS [149]. Both proteins have been implicated in
common signaling pathways. Therefore, a tempting speculation is that
MAVS may link PKR to intra-mitochondrial events. In this context, it is
intriguing that mtDNA stress that is elicited by TFAM depletion potenti-
ates the innate antiviral response [150].
The mechanisms that are responsible for activation of the transcrip-
tional program in the nucleus are far less understood in mammals than
in nematodes. PKR has been suggested to phosphorylate JNK2, which in
turn activates c-Jun, a subunit of AP-1 transcription factor [147,148]. The
activation of AP-1 is a ﬁrst step in the transcriptional activation of
UPRmt genes because it induces the expression of a secondary tran-
scription factor, CHOP10. CHOP10-responsive elements are localized
to multiple genes that are involved in the UPRmt, such as HSP60 or
CLPP although it must be stressed these elements are not exclusive to
UPRmt induced genes and other factors may be required to speciﬁcally
activate this subset of genes [144,151]. Mammalian mitochondria ap-
pear to also possess alternative pathways of stress communication to
the nucleus that are CHOP10-independent and require ROS that are pro-
duced by dysfunctional mitochondria [152–154].
Apart from the nuclear transcriptional program, mitochondrial
stress also activates autonomous mitochondrial responses to restore
proteostasis [155]. These authors used chemical inhibition of mitochon-
drial chaperone TRAP1 and protease LONP1 to evaluate the global re-
sponse of the transcriptome and proteome to acute mitochondrial
proteotoxic stress. In addition to thewell-established activation ofmito-
chondrial chaperones, they observed a decrease in the expression of
MRPP3, a nuclease that is involved in the processing of pre-RNA in mi-
tochondria. Accordingly, pre-RNA processing and mitochondrial trans-
lation were attenuated following TRAP1 inhibition. The inhibition of
mitochondrial translation can serve as a protective mechanism to re-
store the balance between the mitochondrial proteome of nuclear and
mitochondrial origin. Similarly, in nematodes, the accumulation of
mtDNA-encoded transcripts during mitochondrial stress is prevented
by a direct association between ATFS-1 and mtDNA [135].
TheUPRmthas a prominent inﬂuence on the entire organism.One of
themost notable effects of mitochondrial stress is its inﬂuence on aging
in Caenorhabditis elegans. The induction of mitochondrial stress in the
early stage of nematode development increases the lifespan of the
adult animal [156]. The persistent characteristic of this phenomenon
suggests a sustained adaptive response of the organism. This view iscorroborated by a recent discovery that nuclear mechanisms of the
UPRmt involve the epigenetic orchestration of chromatin [138,139]. A
similar phenotype of an increased longevity can be also induced by ac-
tivation of mitophagy [157]. However, activation of the UPRmt can op-
pose mitophagy and by these means can promote the propagation of
deleterious copies of mtDNA [158].
4.2. Signaling mislocalization of mitochondrial proteins: UPRam
Recently, another aspect of mitochondrial signaling has been recog-
nized in yeast, which in contrast to UPRmt regulates proteostasis in the
cytoplasm [120,130,159]. Defective protein import to mitochondria
leads to cellular dysfunction and eventually cell death, demonstrated
by the fact that multiple subunits of mitochondrial translocases are es-
sential for life. Surprisingly, mild impairment in the samemitochondrial
import evokes a protective program referred to as unfolded protein re-
sponse activated by mistargeting of proteins (UPRam), which involves
activation of the proteasome [120] (Fig. 3). An increase inmitochondrial
precursor protein expression in the cytoplasm promotes the assembly
of the proteasome through Irc25 and Poc4, components of the protea-
some assembly chaperone complex (Fig. 3). UPRam can be induced by
either a general impairment of mitochondrial import via the MIA and
TIM23 pathways or the overexpression of mitochondrial precursor pro-
teins. The spectrum of proteasome activators appears to be rather
broad, in which precursors of matrix, IM, and IMS proteins are capable
of increasing proteasomal activity even if they lack sequences that tar-
get them to mitochondria. Regardless of the mechanism that triggers
the accumulation of precursor proteins in the cytoplasm, the propensity
of mislocalizedmitochondrial proteins to stimulate proteasomal activa-
tion raises the possibility of activating the protective program of UPRam
in the absence of general dysfunction of mitochondria. Although the
mechanistic aspects of this signaling pathway are still unclear, a tempt-
ing speculation is that UPRam may be triggered not only by proteins
that fail to be imported but also by peptides and proteins that escape
from mitochondria. This is particularly intriguing in context of soluble
proteins of the IMS that retrotranslocate to the cytosol due to reduction
and metabolic rewiring of mitochondria in yeast [127].
The presence of UPRam in higher eukaryotes has not been veriﬁed,
but proteasomal activation appears to be involved in the response to
some types of mitochondrial proteotoxic stresses in mammalian cells
[152]. Moreover, some responses to mitochondrial proteotoxic stress
can occur independently from the UPRmt. For example, HAF-1 in
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impairing TIM23-dependent mitochondrial import [131,136].
Defects in mitochondria are accompanied by the inhibition of cyto-
solic translation [120,130,159] (Fig. 3). In contrast to proteasomal acti-
vation, a decrease in translation occurs independently from the
accumulation of mitochondrial precursor proteins in the cytoplasm
and likely requires another yet unknown pathway of stress signaling
frommitochondria. The attenuation of translation is elicited by the sta-
bilization of Nog2, which prevents export of the 60S ribosome subunit
from the nucleus, resulting in a lower number of active 80S ribosomes
and polysomes. Together with an increase in proteasomal activity, this
mechanism diminishes protein load in mitochondria and promotes
proteostasis.
The attenuation of translation is beneﬁcial and it may even ex-
tend the life span of organisms [160]. For example, a reduction of cy-
tosolic translation increases longevity in nematodes and preserves
mitochondria from degeneration [160–162]. A general attenuation
of translation is accompanied by the selective translation of speciﬁc
mRNAs that are involved in the stress response [163]. Such a mech-
anism enables the cell to concentrate its efforts on proteins that are
essential for supporting cell survival. A similar phenomenon, induc-
tion of a speciﬁc translational program, may accompany dysfunction
of mitochondria.
4.3. Induction of mitophagy by Parkin/PINK1
Mitochondria-speciﬁc autophagy, also known as mitophagy, serves
as a quality control mechanism that removes damaged mitochondria
from the cell [164–166]. In higher eukaryotes, the key proteins that con-
stitutemitochondrial quality control inmitophagy are themitochondrial
kinase PINK1 and cytosolic E3 ubiquitin ligase Parkin. Mutations in these
genes lead to early-onset Parkinson's disease [167]. Under normal,
steady-state conditions, PINK1 is almost undetectable in cells as it un-
dergoes mitochondrial processing, which ﬁnally leads to degradation
via the proteasome. The PINK1 precursor, via its N-terminal signal se-
quence, is targeted to the TOM complex and then to the TIM23
translocase where it is cleaved by MPP and PARL [168,169]. The N-
terminally processed form of PINK1 does not accumulate in mitochon-
dria and undergoes degradation in the cytosol by the proteasome [168,Fig. 4.PINK1/Parkinmediatedmitophagy. a) In healthymitochondrion full-length PINK1 is impo
theMPP and PARL proteases. This two-step processing generates a N-terminal cleaved form of P
the IM is inhibited and PINK1 accumulates at the outermitochondrial membrane (OM). TOMM7
then phosphorylates both Parkin and ubiquitin (Ub) linked to OM proteins, providing and amp170] (Fig. 4a). With no PINK1 present, Parkin remains inactive in the cy-
tosol, and mitophagy is repressed in cells with functional mitochondria.
However, when ΔΨ is disrupted by mitochondria-depolarizing agents,
OXPHOS inhibitors, or environmental stresses, PINK1 processing by
PARL is blocked, causing the accumulation of uncleaved PINK1 at the
OM [171,172]. This recruits Parkin and eventually leads to the elimina-
tion of dysfunctional mitochondria via mitophagy.
Interestingly, a small subunit of the TOM complex, TOMM7, has been
shown to be essential for stabilizing PINK1 on the outer mitochondrial
membrane following mitochondrial depolarization [173]. Signiﬁcantly
less endogenous PINK1 accumulates followingmitochondrial depolariza-
tion in TOMM7 knockdown cells. Additionally, when ΔΨwas dissipated,
radiolabeled PINK1 that was imported in vitro into TOMM7 knockoutmi-
tochondria failed to associate with the TOM complex. At the same time,
the import of proteins into the matrix was unaffected by TOMM7 knock-
down. This indicates that rather than the generalized protein import the
function of TOMM7 may be more speciﬁc to catch and trap PINK1 and
possibly other proteins. The loss of ΔΨ has been known as a common
mechanism through which different mitochondrial stresses induce
PINK1 accumulation. However, recently unfolded proteins that are
present in the matrix as a result of LONP1 protease deletion have also
been shown to stabilize PINK1 on energetically healthy mitochondria
[174]. LONP1 protease is known to be involved in the degradation of
misfolded proteins, but the mechanism by which this protein stabilizes
PINK1 without depolarizing the IM is still unknown. The authors postu-
lated that the accumulation of unfolded proteins in mitochondria can
act as a physiological trigger of mitophagy.
PINK1 promotes Parkin E3 ligase activity and the subsequent recruit-
ment tomitochondria through a dual regulatorymechanism: (i) it phos-
phorylates Parkin at Ser65 in the N-terminal ubiquitin-like (UBL)
domain [175–178], and (ii) PINK1 phosphorylates conserved Ser65 in
ubiquitin [179–181] (Fig. 4b). This dual phosphorylation of Parkin at
Ser65 and ubiquitin at Ser65 yields maximal Parkin activity. Phospho-
ubiquitin has been shown to bind to Parkin to activate its ligase activity
by releasing Parkin's autoinhibitory domain,which exposes the ubiquitin
ligase active site and allows the ubiquitination of mitochondrial proteins
[182,183]. Once Parkin is recruited to the mitochondria, it dramatically
alters the ubiquitination status of the mitochondrial proteome, which
appears to trigger the recruitment of autophagy-related proteins torted via TOMcomplex to the innermitochondrialmembrane (IM)where it is processed by
INK1which is degraded by the proteasome. b) In depolarizedmitochondria, the import to
is necessary for PINK1 stabilization aftermitochondrial depolarization. PINK1 recruits and
lifying the signal for mitophagy.
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(Fig. 4b). A recent study by Richard Youle's group proposed a novel
model in which PINK1 can induce mitophagy even in the absence of
Parkin, which acts only to amplify the mitophagy signal [187]. In this
model PINK1-generated phospho-ubiquitin plays a primary role in
mitophagy by the recruitment of mitochondrial primary autophagy re-
ceptors (i.e., NDP52 and optineurin). More recently, optineurin has
been shown to be phosphorylated by Tank-binding kinase 1 (TBK1),
which then promotes ubiquitin chain binding and efﬁcient PINK1-
driven and Parkin-independent mitophagy [188,189].
Parkin and PINK1 are undoubtedly central proteins that are involved
in mitophagy clearance, and recent genome-wide RNAi screens have
also identiﬁed several other important PINK1 and Parkin regulators.
Among these, sterol regulatory element binding protein 1 (SREBF1)-de-
pendent lipid synthesis may be a key factor in PINK1 OM stabilization
[190]. However, further work is needed to clarify the ways in which al-
terations in the lipidome alter PINK1 dynamics. Accumulating evidence
suggests that the roles of PINK1 and Parkin in the cell are certainly not
restricted to protein turnover during mitophagy. For example, PINK1
and Parkin may control mitochondrion quality in response to oxidative
stress by modulating the biogenesis of mitochondrial-derived vesicles
(MDVs) that bud off mitochondria and are targeted to the lysosomes
[191]. Interestingly, PINK1 and Parkin have also been shown to play
roles in selective cell death, in which damaged mitochondria are
retained, independent of mitophagy [192].
5. Nuclear-mitochondrial dual localization of proteins
Somemitochondrial proteinsmay localize to other compartments of
the cell. One of the best described examples of this phenomenon is yeast
fumarase, which is present in the mitochondria, cytosol and nucleus,
where it participates in DNA repair [193]. Similarly, in metazoansFig. 5. Nuclear-mitochondrial dual localization of proteins and mitochondrial-derived
peptides (MDPs). PDC (pyruvate dehydrogenase complex), COQ7 (Coenzyme Q
biosynthesis protein 7) and CHCHD2 predominantly localize to mitochondria are also
implicated in the control of the transcription in the nucleus. PDC in the mitochondrial
matrix catalyzes transition of pyruvate to acetyl-CoA whereas in the nucleus participates
in acetylation of histones. Potentially PDC may be delivered to the nucleus via vesicular
pathway analogical to mitochondrial-derived vesicles (MDVs). COQ7 participates in the
ubiquinone biosynthetic pathway in the mitochondrion however, a small pool
translocates to the nucleus in response to the production of ROS by mitochondria.
CHCHD2 in the mitochondria directly binds to the cytochrome c oxidase complex
regulating its activity. Upon the transport to the nucleus which is stimulated by induction
of apoptosis with UV or reduction of oxygen concentration CHCHD2 orchestrates
expression of COX4i2 gene. Tumor suppressor protein p53 in addition to nuclear functions
localizes to mitochondria where participates in the repair of mtDNA.many enzymes that are involved in DNA maintenance, such as TIN2,
TERT, RECQL4 and APE1, have bimodalmito-nuclear localization to sup-
port the stability of nuclear and mitochondrial genomes (discussed in
[194]). The bimodal localization of other proteins serves as a signal to
modify transcriptional programs in the nucleus. In this review, we
focus on one recently described mitochondrial complex and three pro-
teins that have been implicated in the control of transcription in the nu-
cleus (Fig. 5).5.1. Pyruvate dehydrogenase complex
Thepyruvate dehydrogenase complex (PDC) is ametabolicmitochon-
drial complex that is localized to thematrix and catalyzes the transition of
pyruvate to acetyl-CoA in the process of pyruvate decarboxylation
(Fig. 5). Structurally, PDC is composed of six types of proteins with differ-
ent enzymatic activities, forming a large multisubunit complex that
reaches a mass of 9 MDa [195]. A recent report described the accumula-
tion of PDC in the nucleus in the S-phase of the cell cycle where it partic-
ipated in histone acetylation [196]. Intriguingly, the authors suggested
synchronized translocation of the complex from the matrix to the nucle-
us. Thiswas corroborated by the fact that PDC subunits thatwere found in
the nucleus were devoid of presequences, suggesting that the proteins
interacted with MPP prior to nuclear translocation. Moreover, the
accumulation of PDC in the nucleus did not involve de novo-synthesized
proteins, indicated by its resistance to the translation inhibitor cyclohexi-
mide. The possibility of the export of PDC frommitochondria is challeng-
ing because translocases that are located in the IM require unfolded
substrates and transfer proteins unidirectionally. Alternatively, the PDC
may leave mitochondria using a vesicular pathway that is analogous to
MDVs [197]. In fact, MDVs can carry matrix material, and the presence
of PDC subunits in MDVs was previously reported [191,198]. MDVs can
segregate their cargo to peroxisomes or lysosomes, and this pathway
has been recently implicated in the delivery of mitochondrial antigens
to MHC Class I [199]. The assumption that an analogous pathway directs
the PDC to the nucleus is highly speculative, although the involvement
of endosomes in protein delivery to the nucleus has been recently de-
scribed [200].5.2. COQ7
COQ7 is a conserved enzyme of the ubiquinone synthesis pathway,
which contains a cleavable presequence that targets it to the matrix
[201]. It is conserved between nematodes and mammals, and it has
been implicated in the control of the lifespan in these two groups [202,
203]. The parallel nuclear localization of COQ7 and CLK-1 (i.e., a nema-
tode orthologue) has been recently characterized [204] (Fig. 5). In this
case, themechanism of nuclear accumulation does not involve initial im-
port to mitochondria because nuclear forms of COQ7 and CLK-1 are lon-
ger than their mitochondrial counterparts, suggesting the lack of MPP
processing. The sequence, which targets mouse COQ7 to the nucleus,
was identiﬁed upstream from the MPP cleavage site. Under basal condi-
tions, nuclear andmitochondrial import may compete for the full-length
protein, and the ﬁnal balance depends on the effectiveness of both pro-
cesses. Following oxidative stress, nuclear localization prevails, which
can be a derivative of impairments in mitochondrial import pathways
byROS. In the nucleus, COQ7binds to chromatin and changes the expres-
sion patterns of several genes that are related to mechanisms of defense
against ROS (Fig. 5). Intriguingly, it has a negative effect on the expres-
sion of genes that participate in the UPRmt [204]. This effect could ex-
plain the increased longevity phenotype in worms and mice that lack
CLK-1/COQ7 because the mechanisms of the UPRmt should be upregu-
lated in this genetic background. The dependence of CLK-1/COQ7 locali-
zation on oxidative stress also suggests that it can participate in crosstalk
between ROS and the UPRmt.
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CHCHD2 is a human orthologue of yeast Mix17 and is implicated in
the regulation of oxidative phosphorylation and apoptosis [205,206].
Similar to its yeast orthologue, CHCHD2 contains a conserved twin
Cx9Cmotif and is imported by theMIA pathway, indicated by the block-
ade of its accumulation inmitochondria by the ALR inhibitorMitoBlock6
[52,207]. Moreover, CHCHD2 contains a predicted signal sequence, and
rare variants of this sequence are associated with Parkinson's disease
[208]. The function of CHCHD2 in mitochondria is connected to the cy-
tochrome c oxidase complex through direct binding and regulating its
activity. Intriguingly, CHCHD2 also displays nuclear activity as a tran-
scription factor, regulating the expression of a tissue-speciﬁc isoform
of COX4i2 that is prevalently expressed in the lungs [209] (Fig. 5). To-
gether with two other transcription factors (i.e., RBPJ and CXXC5), it or-
chestrates the expression of COX4i2 via interactions with a regulatory
element in its promoter in response to oxygen concentration. The activ-
ity of the promoter and presence of CHCHD2 in the nucleus increase in
response to reduction of oxygen concentration (from 20% to 4%). The
translocation of CHCHD2 to thenucleus can also be stimulated by the in-
duction of apoptosis by ultraviolet light, although its activity as a tran-
scription factor in this case has not been veriﬁed [206]. A tempting
speculation is that the concentration of oxygen, which is a ﬁnal acceptor
of electrons that are delivered by the MIA pathway, can control the dis-
tribution of CHCHD2 in the cell and consequentlymodify the expression
of COX4i2 in speciﬁc tissues.
5.4. p53
p53 is a tumor suppressor, which acts as a transcription factor that is
involved in the control of cell cycle and genome integrity and is one of
the most frequent targets for mutations in cancer-related malignancies.
One of the most prominent roles of p53 is induction of cell cycle arrest
in response to various cellular stresses. Oxidative stress, UV irradiation
and other noxious stimuli lead to accumulation of p53 in the nucleus
and transcriptional induction of p21, which triggers cell cycle arrest via
interactions with cyclins giving the cell an opportunity to repair DNA
[210]. Unsuccessful DNA repair leads to the programmed cell death, in
which p53 participates as an activator of OM permeabilization via its in-
teractions with Bcl2 family proteins. A recent report demonstrated that
p53 is present in the mitochondrial matrix where it supports mtDNA in-
tegrity [211,212]. Import of p53 is supported by theMIApathway but the
machinery, which drives translocation of p53 across the IM, is not
known. In this respectmitochondrial import of p53 resembles biogenesis
of APE1 in mitochondria, which also participates in DNAmaintenance in
the nucleus and mitochondria [68]. Interestingly, the transcriptional ac-
tivity of p53 is controlled by MIA40, which limits its translocation to
the nucleus upon induction of oxidative stress. Similar to CHCHD2 trans-
location, the MIA pathway may compete for p53 and thereby regulate
the nuclear activity of the transcription factor (Fig. 5). Interestingly, the
overexpression ofMIA40 positively correlates with the severity of sever-
al tumors [213]. It is tempting to speculate that the MIA pathway may
regulate the localization of p53 in cancer cells to abolish its control
over the integrity of nuclear DNA.
6. Mitochondrial-derived peptides
An interesting trait of the UPRmt in C. elegans is the cell-non-
autonomous characteristic of adaptations. Proteotoxic stress that is elicit-
ed in a single tissue in awormcan induce theUPRmt in another tissue and
extend the lifespan of the organism as awhole [214]. This discovery led to
the concept of a “mitokine” (i.e., an extracellular signal that can be deliv-
ered to different parts of the body to synchronize the response to stress).
The mitokine theory has received support from recent experiments in
mammals, which identiﬁed mitochondrial-derived peptides (MDPs).
MDPs are peptides that are encoded in the mitochondrial genome byshort open reading frames (ORFs) that are located in genes for 12S and
16S rRNA [215]. To date, several sequences of MDPs have been identiﬁed,
including humanin, small humanin-like peptides, and the mitochondrial
ORF within the 12S rRNA c (MOTS-c), which vary in length from 16 to
38 amino acids [215]. The main concern regarding the mitochondrial or-
igin of MDPs is a process known as nuclear mitochondrial DNA transfer
(NUMT). Over millions of years of co-evolution, NUMT resulted in the
presence of MDP paralogs in the nuclear genome. In some cases, it is dif-
ﬁcult to verify whether a certain peptide is translated fromnuclear ormi-
tochondrial mRNA or at the mitochondrial or cytosolic ribosomes. The
location of MDP translation appears to be peptide-speciﬁc. For example,
rat humanin is translated by mitochondrial ribosomes, whereas human
MOTS-c undergoes translation in the cytosol [216,217]. The mechanisms
that participate in the export of peptides and/or mRNA that encode
MDPs are unknown. MDPs are relatively short, with an average mass in
the range of 2000-3000 Da, which is slightly more than the size of pep-
tides that are released from yeast mitochondria by the ABC transporter
Mdl1 [116]. This suggests a specialized export pathway. Similarly, the re-
lease of RNA frommitochondria was also described, although themecha-
nisms that underlie this phenomenon are still unknown [218,219].
Regardless of the exact mechanism of MDP biogenesis, these pep-
tides appear to have a profound effect on the cell and entire organism.
For example, humanin exerts cytoprotective effects in numerous
models of pathological conditions, both in cultured cells and in living
animals [220]. MDPs can be released from the cell to the plasma and
function as paracrine or endocrine factors. Interestingly, the plasma
levels of humanin correlate with the physiological state of the organism
and can decrease during aging of humans and mice.
A recent report by Lee at al. demonstrated a comprehensive ap-
proach to characterize the inﬂuence of MOTS-c onmetabolic homeosta-
sis at the cellular and organismal levels [216]. In cultured cells, MOTS-c
inhibited the methionine-folate cycle, which led to the accumulation of
5-aminoimidazole-4-carboxamide ribonucleotide and activation of
adenosine monophosphate-activated protein kinase signaling. Conse-
quently, glucose metabolism was shifted to glycolysis and the pentose
phosphate pathway. Thesemodiﬁcations had a prominent effect on glu-
cose homeostasis at the organismal level. Repeated intraperitoneal ad-
ministration of MOTS-c in mice resulted in an increase in insulin
sensitivity in skeletal muscles, which prevented the development of
the deleterious consequences of high-fat-diet intake, such as obesity
and insulin resistance [216].
MDPs meet the criteria of a “mitokine” because their biogenesis is
linked tomitochondria, and they have a paracrine and endocrine impact
on the whole organism. MPDs could function as a feedback signal from
actively transcribing mitochondria to synchronize metabolism at the
systemic level.7. Conclusions and perspectives
Mitochondria are vital component of the eukaryotic cell and their role
in cellular signaling is well established. In this review we focus on the
speciﬁc aspect of mitochondrial retrograde signaling, which involves
themechanisms ofmitochondrial protein biogenesis. Our understanding
of these processes improved substantially over the recent years. The
spectrum of programs, which mitochondria can activate, ranges from
organellar to global rearrangements of metabolism on the organismal
level. This apparent complexity raises a question about hierarchy and co-
ordination between variousmodes ofmitochondrial signaling. For exam-
ple, mitophagy and UPRam respond to such closely correlated triggers
like invalid protein import and accumulation of mitochondrial precur-
sors in the cytosol. Similarly, accumulation of unfolded proteins in the
mitochondrial matrix activates UPRmt and mitophagy. It is intriguing
to which extent these mechanisms overlap in terms of triggers and out-
puts, and how efﬁciently they can be manipulated. These questions may
have long-awaited practical implications given a longevity phenotype of
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ic mechanisms.
Another interesting question is the role of bimodal localization of
mitochondrial proteins, which according to the estimates from yeast
may concern a signiﬁcant fraction of mitochondrial proteome [221].
Our understanding of these processes is still rudimental. Most likely,
the translocation of these proteins involve non-canonical pathways. Fu-
ture studies may reveal novel mechanisms, which allow facultative lo-
calization in or out of mitochondria.
Mitochondrial retrograde signalingmay involve peptides encoded in
the mtDNA. The concept of mitochondrialy encoded factors, which
eventually act as endocrine regulators, is fascinating and opens a new
ﬁeld of possible regulatorymechanisms at the organismal level. Howev-
er, it needs to be said that there is nomechanistic model to explain how
transcripts or peptides leave mitochondria so far and without this criti-
cal step the mitochondrial origin of MOTS-c or humanin may be
questioned.
We would like to conclude with a notion that mechanisms of mito-
chondrial biogenesis, once thoroughly characterized in yeast, do not
stop to surprise and to bring thrilling developments, which hopefully
will improve the understanding of ourselves.
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